Stryker Corporation (SYK) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.096x

Based on the latest financial reports, Stryker Corporation (SYK) has a cash flow conversion efficiency ratio of 0.096x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.14 Billion) by net assets ($22.42 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Stryker Corporation - Cash Flow Conversion Efficiency Trend (1989–2025)

This chart illustrates how Stryker Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SYK total debt and obligations for a breakdown of total debt and financial obligations.

Stryker Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stryker Corporation ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
UNICREDIT S.P.A. ADR
F:CRIP
N/A
Altria Group
NYSE:MO
-0.948x
Capital One Financial Corporation
NYSE:COF
0.069x
China Merchants Bank Co Ltd
SHG:600036
0.030x
Corning Incorporated
NYSE:GLW
0.085x
China Life Insurance Co Ltd A
SHG:601628
0.225x
FAST RETAIL.CO.SP.HDR 1
F:FR7H
N/A
Parker-Hannifin Corporation
NYSE:PH
0.060x

Annual Cash Flow Conversion Efficiency for Stryker Corporation (1989–2025)

The table below shows the annual cash flow conversion efficiency of Stryker Corporation from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see Stryker Corporation (SYK) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $22.42 Billion $5.04 Billion 0.225x +9.43%
2024-12-31 $20.63 Billion $4.24 Billion 0.206x +3.00%
2023-12-31 $18.59 Billion $3.71 Billion 0.200x +26.39%
2022-12-31 $16.62 Billion $2.62 Billion 0.158x -28.00%
2021-12-31 $14.88 Billion $3.26 Billion 0.219x -12.43%
2020-12-31 $13.08 Billion $3.28 Billion 0.250x +46.40%
2019-12-31 $12.81 Billion $2.19 Billion 0.171x -23.11%
2018-12-31 $11.73 Billion $2.61 Billion 0.223x +42.64%
2017-12-31 $9.99 Billion $1.56 Billion 0.156x -22.21%
2016-12-31 $9.55 Billion $1.92 Billion 0.201x +89.84%
2015-12-31 $8.51 Billion $899.00 Million 0.106x -49.05%
2014-12-31 $8.60 Billion $1.78 Billion 0.207x -0.56%
2013-12-31 $9.05 Billion $1.89 Billion 0.208x +8.16%
2012-12-31 $8.60 Billion $1.66 Billion 0.193x +3.27%
2011-12-31 $7.68 Billion $1.43 Billion 0.187x -13.47%
2010-12-31 $7.17 Billion $1.55 Billion 0.216x -2.61%
2009-12-31 $6.60 Billion $1.46 Billion 0.221x +1.84%
2008-12-31 $5.41 Billion $1.18 Billion 0.217x +13.76%
2007-12-31 $5.38 Billion $1.03 Billion 0.191x -7.61%
2006-12-31 $4.19 Billion $867.30 Million 0.207x -22.10%
2005-12-31 $3.25 Billion $863.80 Million 0.266x +24.94%
2004-12-31 $2.79 Billion $593.30 Million 0.213x -29.36%
2003-12-31 $2.15 Billion $648.50 Million 0.301x -10.52%
2002-12-31 $1.50 Billion $503.90 Million 0.336x -24.14%
2001-12-31 $1.06 Billion $468.30 Million 0.443x +14.24%
2000-12-31 $854.90 Million $331.80 Million 0.388x -8.23%
1999-12-31 $671.50 Million $284.00 Million 0.423x +83.08%
1998-12-31 $668.80 Million $154.50 Million 0.231x +63.01%
1997-12-31 $648.50 Million $91.90 Million 0.142x -57.25%
1996-12-31 $616.30 Million $204.30 Million 0.331x +66.28%
1995-12-31 $559.30 Million $111.50 Million 0.199x -6.48%
1994-12-31 $458.30 Million $97.70 Million 0.213x -28.59%
1993-12-31 $288.40 Million $86.10 Million 0.299x +36.79%
1992-12-31 $232.30 Million $50.70 Million 0.218x +4.42%
1991-12-31 $179.90 Million $37.60 Million 0.209x -36.00%
1990-12-31 $147.90 Million $48.30 Million 0.327x +70.12%
1989-12-31 $112.00 Million $21.50 Million 0.192x --

About Stryker Corporation

NYSE:SYK USA Medical Devices
Market Cap
$112.79 Billion
Market Cap Rank
#208 Global
#110 in USA
Share Price
$294.73
Change (1 day)
-6.47%
52-Week Range
$294.73 - $403.53
All Time High
$403.53
About

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more